Fifth Third Bancorp Buys 12,998 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Fifth Third Bancorp raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 7.0% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 199,932 shares of the medical equipment provider's stock after buying an additional 12,998 shares during the quarter. Fifth Third Bancorp owned approximately 0.06% of Intuitive Surgical worth $104,357,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. State Street Corp boosted its position in Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock worth $7,393,673,000 after acquiring an additional 210,363 shares during the period. FMR LLC raised its stake in shares of Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock valued at $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider's stock worth $3,677,194,000 after purchasing an additional 143,440 shares during the period. Fisher Asset Management LLC grew its position in Intuitive Surgical by 1.8% in the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider's stock valued at $2,349,441,000 after buying an additional 86,208 shares in the last quarter. Finally, Baillie Gifford & Co. increased its stake in Intuitive Surgical by 0.6% during the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider's stock valued at $1,890,676,000 after buying an additional 24,183 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Down 4.0 %

Shares of ISRG traded down $24.61 during trading hours on Friday, reaching $584.05. The company's stock had a trading volume of 4,350,539 shares, compared to its average volume of 1,342,626. The company has a 50 day moving average of $547.16 and a two-hundred day moving average of $504.35. The firm has a market cap of $208.03 billion, a price-to-earnings ratio of 93.90, a P/E/G ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Insider Activity at Intuitive Surgical

In other news, CEO Gary S. Guthart sold 18,151 shares of the firm's stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Jamie Samath sold 108 shares of the company's stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares of the company's stock, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 42,475 shares of company stock valued at $22,070,807. Corporate insiders own 0.90% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. Evercore ISI reiterated a "cautious" rating on shares of Intuitive Surgical in a report on Friday, October 18th. Stifel Nicolaus lifted their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a research report on Thursday, December 5th. Royal Bank of Canada boosted their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the stock an "outperform" rating in a research note on Friday, October 18th. Piper Sandler reaffirmed an "overweight" rating and set a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday. Finally, Mizuho boosted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average target price of $583.83.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.